Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00594425 · ClinicalTrials.gov registry record · Phase 2
Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Moderate to Severe Acne
A Phase 2 study, sponsored by Photocure.
- Completed
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
NCT00594425 is a Phase 2 study that has completed, run by Photocure. The registered enrollment target is 150 participants.
The verdict
NCT00594425, a Phase 2 study, has completed, sponsored by Photocure.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
Study Summary
This multicenter study will be divided into 2 phases. The first phase will be an open label, dose-escalation phase, while the second will be a blinded, randomized, vehicle-controlled, parallel-group, dose-response phase. The second phase will only start if the first phase succeeds in establishing well tolerated dose(s). Patients with moderate to severe acne vulgaris in the face will be included.The results from part 2 has been presented in the result section.
Interventions
- DRUG Methyl aminolevulinate (MAL) PDT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2007-02 |
| Est. Completion | 2008-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00594425
The ClinicalTrials.gov registry entry for NCT00594425 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Photocure, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Methyl aminolevulinate (MAL) PDT is the first listed.
NCT00594425 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00594425 about?
NCT00594425 is a clinical study titled "Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Moderate to Severe Acne". This multicenter study will be divided into 2 phases. The first phase will be an open label, dose-escalation phase, while the second will be a blinded, randomized, vehicle-controlled, parallel-group, dose-response phase. The second phase will only start if the first phase succeeds in establishing we...
What is the current status of trial NCT00594425?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2007-02. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00594425?
The interventions under investigation include: Methyl aminolevulinate (MAL) PDT (DRUG).
Who is sponsoring clinical trial NCT00594425?
This trial is sponsored by Photocure, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.